Coherus Oncology Inc (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 475,824 | 356,071 | 0 | 1,556 | 190,106 |
| Cost of Goods | 37,667 | 17,078 | N/A | N/A | N/A |
| Gross Profit | 438,157 | 338,993 | N/A | 1,556 | 190,106 |
| Operating Expenses | 282,505 | 231,303 | 204,416 | 233,692 | 306,037 |
| Operating Income | 156,319 | 107,768 | -204,416 | -232,136 | -115,931 |
| Interest Expense | 21,166 | 17,601 | 9,684 | 9,552 | 7,980 |
| Other Income | 554 | 2,608 | 4,691 | 3,402 | -3,877 |
| Pre-tax Income | 135,707 | 92,775 | -209,409 | -238,286 | -127,788 |
| Income Tax | 3,463 | 2,942 | N/A | N/A | N/A |
| Net Income Continuous | 132,244 | 89,833 | -209,409 | -238,286 | -127,788 |
| Minority Interests | N/A | N/A | -70 | -116 | -451 |
| Net Income | $132,244 | $89,833 | $-209,339 | $-238,170 | $-127,337 |
| EPS Basic Total Ops | 1.85 | 1.29 | -3.22 | -4.48 | -3.04 |
| EPS Basic Continuous Ops | 1.85 | 1.29 | -3.22 | -4.48 | -3.05 |
| EPS Diluted Total Ops | 1.62 | 1.23 | -3.22 | -4.48 | -3.04 |
| EPS Diluted Continuous Ops | 1.58 | 1.23 | -3.22 | -4.48 | -3.05 |
| EPS Diluted Before Non-Recurring Items | 1.62 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $159,207 | $111,027 | $-201,181 | $-228,738 | $-112,935 |